Mitral regurgitation and atrial fibrillation recurrence in hypertrophic cardiomyopathy: association or modifiable substrate?
Cardiovascular Diagnosis and Therapy · 2026-06 · 16 (3) · 56-56
DOI: 10.21037/cdt-2026-0229 ↗Kurz gefasst
Leserbrief in der Zeitschrift Cardiovascular Diagnosis and Therapy, 2026-06. Verfasst von Teruhiko Imamura. Beteiligte Einrichtung: Second Department of Internal Medicine, University of Toyama, Toyama, Japan. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Second Department of Internal Medicine, University of Toyama, Toyama, Japan.
Zitieren
APA
Imamura, T. (2026). Mitral regurgitation and atrial fibrillation recurrence in hypertrophic cardiomyopathy: association or modifiable substrate?. Cardiovascular Diagnosis and Therapy, 16(3), 56-56. https://doi.org/10.21037/cdt-2026-0229
Vancouver
Imamura T. Mitral regurgitation and atrial fibrillation recurrence in hypertrophic cardiomyopathy: association or modifiable substrate?. Cardiovascular Diagnosis and Therapy. 2026;16(3):56-56. doi:10.21037/cdt-2026-0229
BibTeX
@article{Imamura2026,
author = {Imamura, Teruhiko},
title = {Mitral regurgitation and atrial fibrillation recurrence in hypertrophic cardiomyopathy: association or modifiable substrate?},
journal = {Cardiovascular Diagnosis and Therapy},
year = {2026},
volume = {16},
number = {3},
pages = {56--56},
doi = {10.21037/cdt-2026-0229}
}
EUVIMED